These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26825094)

  • 1. Increased Epileptiform EEG Activity and Decreased Seizure Threshold in Arctic APP Transgenic Mouse Model of Alzheimer's Disease.
    Ziyatdinova S; Rönnbäck A; Gurevicius K; Miszczuk D; Graff C; Winblad B; Pitkänen A; Tanila H
    Curr Alzheimer Res; 2016; 13(7):817-30. PubMed ID: 26825094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure susceptibility in the APP/PS1 mouse model of Alzheimer's disease and relationship with amyloid β plaques.
    Reyes-Marin KE; Nuñez A
    Brain Res; 2017 Dec; 1677():93-100. PubMed ID: 28963050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of epileptiform activity by valproic acid in a mouse model of Alzheimer's disease is not long-lasting after treatment discontinuation.
    Ziyatdinova S; Viswanathan J; Hiltunen M; Tanila H; Pitkänen A
    Epilepsy Res; 2015 May; 112():43-55. PubMed ID: 25847338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L; Sun Y; Guo Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    Curr Alzheimer Res; 2018; 15(11):1053-1061. PubMed ID: 29984654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.
    Born HA; Kim JY; Savjani RR; Das P; Dabaghian YA; Guo Q; Yoo JW; Schuler DR; Cirrito JR; Zheng H; Golde TE; Noebels JL; Jankowsky JL
    J Neurosci; 2014 Mar; 34(11):3826-40. PubMed ID: 24623762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
    Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer's Disease.
    Allué JA; Sarasa L; Izco M; Pérez-Grijalba V; Fandos N; Pascual-Lucas M; Ogueta S; Pesini P; Sarasa M
    J Alzheimers Dis; 2016 May; 53(3):773-85. PubMed ID: 27258422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seizures in Alzheimer's disease.
    Born HA
    Neuroscience; 2015 Feb; 286():251-63. PubMed ID: 25484360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
    Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
    J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid neuropathology in the single Arctic APP transgenic model affects interconnected brain regions.
    Rönnbäck A; Sagelius H; Bergstedt KD; Näslund J; Westermark GT; Winblad B; Graff C
    Neurobiol Aging; 2012 Apr; 33(4):831.e11-9. PubMed ID: 21880397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.
    Rönnbäck A; Pavlov PF; Mansory M; Gonze P; Marlière N; Winblad B; Graff C; Behbahani H
    J Neurochem; 2016 Feb; 136(3):497-502. PubMed ID: 26500157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels.
    Ziyatdinova S; Gurevicius K; Kutchiashvili N; Bolkvadze T; Nissinen J; Tanila H; Pitkänen A
    Epilepsy Res; 2011 Mar; 94(1-2):75-85. PubMed ID: 21300523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Aβ over-production produces diffuse and compact Alzheimer-type amyloid deposits.
    Xu G; Ran Y; Fromholt SE; Fu C; Yachnis AT; Golde TE; Borchelt DR
    Acta Neuropathol Commun; 2015 Nov; 3():72. PubMed ID: 26566997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low brain ascorbic acid increases susceptibility to seizures in mouse models of decreased brain ascorbic acid transport and Alzheimer's disease.
    Warner TA; Kang JQ; Kennard JA; Harrison FE
    Epilepsy Res; 2015 Feb; 110():20-5. PubMed ID: 25616451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease.
    George S; Rönnbäck A; Gouras GK; Petit GH; Grueninger F; Winblad B; Graff C; Brundin P
    Acta Neuropathol Commun; 2014 Feb; 2():17. PubMed ID: 24517102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of β-amyloid accumulation by reticulon 3 in transgenic mice.
    Araki W; Oda A; Motoki K; Hattori K; Itoh M; Yuasa S; Konishi Y; Shin RW; Tamaoka A; Ogino K
    Curr Alzheimer Res; 2013 Feb; 10(2):135-42. PubMed ID: 22742855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of cortical EEG in mice carrying mutated human APP transgene.
    Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H
    Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.